These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 2165422

  • 1. Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects.
    Cameron OG, Smith CB, Lee MA, Hollingsworth PJ, Hill EM, Curtis GC.
    Biol Psychiatry; 1990 Jul 01; 28(1):3-20. PubMed ID: 2165422
    [Abstract] [Full Text] [Related]

  • 2. Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives.
    Cameron OG, Smith CB, Nesse RM, Hill EM, Hollingsworth PJ, Abelson JA, Hariharan M, Curtis GC.
    Psychosom Med; 1996 Jul 01; 58(4):289-301. PubMed ID: 8827791
    [Abstract] [Full Text] [Related]

  • 3. Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors.
    Grunhaus LJ, Cameron O, Pande AC, Haskett RF, Hollingsworth PJ, Smith CB.
    Acta Psychiatr Scand; 1990 Mar 01; 81(3):216-9. PubMed ID: 2160772
    [Abstract] [Full Text] [Related]

  • 4. Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety.
    Cameron OG, Smith CB, Hollingsworth PJ, Nesse RM, Curtis GC.
    Arch Gen Psychiatry; 1984 Dec 01; 41(12):1144-8. PubMed ID: 6095785
    [Abstract] [Full Text] [Related]

  • 5. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS, Heninger GR, Breier A.
    Arch Gen Psychiatry; 1984 Aug 01; 41(8):751-63. PubMed ID: 6742977
    [Abstract] [Full Text] [Related]

  • 6. Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal.
    Braune S, Albus M, Fröhler M, Höhn T, Scheibe G.
    Eur Arch Psychiatry Clin Neurosci; 1994 Aug 01; 244(2):86-92. PubMed ID: 7948059
    [Abstract] [Full Text] [Related]

  • 7. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS, Heninger GR.
    Arch Gen Psychiatry; 1986 Nov 01; 43(11):1042-54. PubMed ID: 3021083
    [Abstract] [Full Text] [Related]

  • 8. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR.
    Acta Psychiatr Scand; 1992 Oct 01; 86(4):273-82. PubMed ID: 1333719
    [Abstract] [Full Text] [Related]

  • 9. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
    Charney DS, Woods SW, Goodman WK, Heninger GR.
    Am J Psychiatry; 1987 Aug 01; 144(8):1030-6. PubMed ID: 3037926
    [Abstract] [Full Text] [Related]

  • 10. Platelet alpha 2 adrenoreceptors in chronic congestive heart failure.
    Weiss RJ, Tobes M, Wertz CE, Smith CB.
    Am J Cardiol; 1983 Jul 01; 52(1):101-5. PubMed ID: 6305182
    [Abstract] [Full Text] [Related]

  • 11. Noradrenergic and serotonergic receptor system function in panic disorder and depression.
    Heninger GR, Charney DS, Price LH.
    Acta Psychiatr Scand Suppl; 1988 Jul 01; 341():138-50. PubMed ID: 3048049
    [Abstract] [Full Text] [Related]

  • 12. Platelet binding studies in panic disorder.
    Nutt DJ, Fraser S.
    J Affect Disord; 1987 Jul 01; 12(1):7-11. PubMed ID: 3033042
    [Abstract] [Full Text] [Related]

  • 13. Sympathetic nervous system activity in panic disorder.
    Villacres EC, Hollifield M, Katon WJ, Wilkinson CW, Veith RC.
    Psychiatry Res; 1987 Aug 01; 21(4):313-21. PubMed ID: 3628614
    [Abstract] [Full Text] [Related]

  • 14. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA, Ward K, Malpass T, Stratton J, Halter J, Evans M, Beiter H, Harker LA, Porte D.
    J Clin Invest; 1984 Sep 01; 74(3):1063-72. PubMed ID: 6088579
    [Abstract] [Full Text] [Related]

  • 15. Blunted growth hormone response to clonidine in panic disorder patients.
    Uhde TW, Vittone BJ, Siever LJ, Kaye WH, Post RM.
    Biol Psychiatry; 1986 Sep 01; 21(11):1081-5. PubMed ID: 3741921
    [No Abstract] [Full Text] [Related]

  • 16. Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder.
    Charney DS, Woods SW, Heninger GR.
    Psychiatry Res; 1989 Feb 01; 27(2):173-82. PubMed ID: 2540501
    [Abstract] [Full Text] [Related]

  • 17. Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects.
    Sevy S, Papadimitriou GN, Surmont DW, Goldman S, Mendlewicz J.
    Biol Psychiatry; 1989 Jan 15; 25(2):141-52. PubMed ID: 2539200
    [Abstract] [Full Text] [Related]

  • 18. Alpha 2-adrenoreceptor status in obsessive-compulsive disorder.
    Lee MA, Cameron OG, Gurguis GN, Glitz D, Smith CB, Hariharan M, Abelson JL, Curtis GC.
    Biol Psychiatry; 1990 May 15; 27(10):1083-93. PubMed ID: 2160292
    [Abstract] [Full Text] [Related]

  • 19. Platelet [3H]imipramine binding in generalized anxiety disorder, panic disorder, and agoraphobia with panic attacks.
    Schneider LS, Munjack D, Severson JA, Palmer R.
    Biol Psychiatry; 1987 Jan 15; 22(1):59-66. PubMed ID: 3790641
    [Abstract] [Full Text] [Related]

  • 20. Heart rate and blood pressure changes during postural change and isometric handgrip exercise in patients with panic disorder and normal controls.
    Yeragani VK, Meiri PC, Pohl R, Balon R, Desai N, Golec S.
    Acta Psychiatr Scand; 1990 Jan 15; 81(1):9-13. PubMed ID: 2330838
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.